Concepedia

J. J. Kavanagh

JJ

Statistics

Publications

55

Citations

3.3K

H-Index

32

Active since

1984

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Chulalongkorn University

University of South Florida

Gynecologic Oncology Group

Roche (Switzerland)

J. J. Kavanagh is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and obstetrics.

Top concepts

Publications per year

1984–2017

55

Publications

55

13-cis-Retinoic Acid Plus Interferon   -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

S. M. Lippman, J. J. Kavanagh, M. Paredes-Espinoza et al. · JNCI Journal of the National Cancer Institute · 1992 · 323 citations

Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.

David M. Gershenson, Michael B. Morris, J. J. Kavanagh et al. · Journal of Clinical Oncology · 1990 · 266 citations

, , +13

Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.

Andrzej P. Kudelka, Damrong Tresukosol, Creighton L. Edwards et al. · Journal of Clinical Oncology · 1996 · 252 citations

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy

Elie G. Hanania, Richard E. Giles, J. J. Kavanagh et al. · Proceedings of the National Academy of Sciences · 1996 · 152 citations · Full text

Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later

Claire F. Verschraegen, Mongkol Benjapibal, W. Supakarapongkul et al. · International Journal of Gynecological Cancer · 2001 · 151 citations

1–5 of 55